scholarly journals Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)

2018 ◽  
Vol 17 (1) ◽  
Author(s):  
Mikhail Kosiborod ◽  
◽  
Marilia B. Gomes ◽  
Antonio Nicolucci ◽  
Stuart Pocock ◽  
...  
2020 ◽  
Vol 11 ◽  
pp. 215013272095996
Author(s):  
Akila Govindarajan Venguidesvarane ◽  
Aliya Jasmine ◽  
Samya Varadarajan ◽  
Vanishree Shriraam ◽  
Anitha Rani Muthuthandavan ◽  
...  

Introduction: Vascular complications are the major cause of morbidity in patients with diabetes mellitus. Screening for these complications is crucial in early detection and tertiary prevention. Hence, this study aimed at finding the prevalence of micro and macrovascular complications and their associated factors in type 2 diabetes mellitus patients in a rural health center by using simple and easily available tools. Methodology: This hospital based cross sectional study was conducted in Rural Health and Training Centre (RHTC) of Sri Ramachandra medical college from Jan 2017 to Aug 2017. All type 2 diabetes patients registered at RHTC were included in the study. By the use of questionnaire, clinical examination and laboratory investigations, the prevalence of macro and microvascular complications and associated factors were ascertained. Multiple logistic regression was used to identify factors associated with vascular complications of diabetes. Results: The study included 390 type 2 diabetes patients. The overall prevalence of macrovascular and microvascular complications in our study population was 29.7% and 52.1%, respectively. Among the macrovascular complications, both coronary artery disease (CAD) and peripheral vascular disease (PVD) had a prevalence rate of 15.1%. Among the microvascular complications, peripheral neuropathy (44.9%) had the highest prevalence followed by nephropathy (12.1%) and diabetic foot (7.2%). Multiple logistic regression analyses showed high HbA1c level, lower education, high postprandial blood sugar, hypertension, abdominal obesity were significantly associated with increased risk of vascular complications of diabetes. Conclusion: This study demonstrated the increased prevalence of vascular complications in Type 2 diabetes patients in rural India. Regular screening to identify those patients at risk could prevent further progression of complications.


Author(s):  
Venkataiah Gudise ◽  
Bimalendu Chowdhury

Abstract Background Type 2 diabetes in obese (≥ 25 and ≥ 30 kg/m2) patients is the foremost cause of cardiovascular complications like stroke, osteoarthritis, cancers (endometrial, breast, ovarian, liver, kidney, colon, and prostate), and vascular complications like diabetic neuropathy, diabetic and retinopathy, and diabetic nephropathy. It is recognized as a global burden disorder with high prevalence in middle-income nations which might lead to a double burden on health care professionals. Hence, this review emphasizes on understanding the complexity and vital signaling tracts involved in diabetic complications for effective treatment. Main body Type 2 diabetes in overweight patients induces the creation of specific ROS that further leads to changes in cellular proliferation, hypothalamus, and fringe. The resistin, TLR4, and NF-κB signalings are mainly involved in the progression of central and fringe changes such as insulin resistance and inflammation in diabetic patients. The overexpression of these signals might lead to the rapid progression of diabetic vascular complications induced by the release of proinflammatory cytokines, chemokines, interleukins, and cyclooxygenase-mediated chemicals. Until now, there has been no curative treatment for diabetes. Therefore, to effectively treat complications of type 2 diabetes, the researchers need to concentrate on the molecular mechanisms and important signaling tracts involved. Conclusion In this review, we suggested the molecular mechanism of STZ-HFD induced type 2 diabetes and the vital roles of resistin, TLR4, and NF-κB signalings in central, fringe changes, and development diabetic complications for its effective treatment. Graphical abstract


Diabetologia ◽  
2005 ◽  
Vol 48 (4) ◽  
pp. 695-702 ◽  
Author(s):  
T. M. E. Davis ◽  
A. D. Wright ◽  
Z. M. Mehta ◽  
C. A. Cull ◽  
I. M. Stratton ◽  
...  

2017 ◽  
Vol 31 (7) ◽  
pp. 1169-1174 ◽  
Author(s):  
Richard Gauci ◽  
Michael Hunter ◽  
David G. Bruce ◽  
Wendy A. Davis ◽  
Timothy M.E. Davis

Drugs ◽  
2013 ◽  
Vol 73 (4) ◽  
pp. 327-339 ◽  
Author(s):  
Joe M. Chehade ◽  
Margaret Gladysz ◽  
Arshag D. Mooradian

Sign in / Sign up

Export Citation Format

Share Document